427 results on '"Guo, Ju-Tao"'
Search Results
2. The HBV capsid modulators derived from sulfamoylbenzamides and benzamides: an overview of the progress of patents
3. RNA binding protein TIAR modulates HBV replication by tipping the balance of pgRNA translation
4. Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy
5. Identification of novel tetrahydroquinoxaline derived phenyl ureas as modulators of the hepatitis B virus nucleocapsid assembly
6. Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development
7. Identification of hepatitis B virus core protein residues critical for capsid assembly, pgRNA encapsidation and resistance to capsid assembly modulators
8. Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B
9. Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus
10. Synthesis of 4-oxotetrahydropyrimidine-1(2H)-carboxamides derivatives as capsid assembly modulators of hepatitis B virus
11. Long‐term antiviral therapy is associated with changes in the profile of transcriptionally active HBV integration in the livers of patients with CHB.
12. CpAMs induce assembly of HBV capsids with altered electrophoresis mobility: Implications for mechanism of inhibiting pgRNA packaging
13. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo
14. Characterization of CCoV-HuPn-2018 spike protein-mediated viral entry
15. A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists
16. In Vitro Anti-hepatitis B Virus Activity of 2′,3′-Dideoxyguanosine
17. Characterization of Serum Amyloid A Protein mRNA Expression and Secondary Amyloidosis in the Domestic Duck
18. Characterization of novel hepadnaviral RNA species accumulated in hepatoma cells treated with viral DNA polymerase inhibitors
19. Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics
20. Treatment of chronic hepatitis B with pattern recognition receptor agonists: Current status and potential for a cure
21. Overview of Hepatitis Viruses and Cancer
22. Heat Shock Protein Family A Member 1 Promotes Intracellular Amplification of Hepatitis B Virus Covalently Closed Circular DNA
23. Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis
24. Therapeutic strategies for a functional cure of chronic hepatitis B virus infection
25. An interferon-beta promoter reporter assay for high throughput identification of compounds against multiple RNA viruses
26. A research agenda for curing chronic hepatitis B virus infection
27. Interferon induction of IFITM proteins promotes infection by human coronavirus OC43
28. Characterization of the Interferon Alpha Response Against HCV in Hepatoma Cells
29. Antiviral therapies targeting host ER alpha-glucosidases: Current status and future directions
30. Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses
31. The innate immune response to hepatitis B virus infection: Implications for pathogenesis and therapy
32. The Ebola Virus Glycoprotein and HIV-1 Vpu Employ Different Strategies to Counteract the Antiviral Factor Tetherin
33. 4-Oxooctahydroquinoline-1(2H)-carboxamides as hepatitis B virus (HBV) capsid core protein assembly modulators
34. Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo
35. Antiviral activities of ISG20 in positive-strand RNA virus infections
36. A yellow fever virus NS4B inhibitor not only suppresses viral replication, but also enhances the virus activation of RIG-I-like receptor-mediated innate immune response
37. Amino acid residues at core protein dimer-dimer interface modulate multiple steps of hepatitis B virus replication and HBeAg biogenesis
38. Present and Future Therapies of Hepatitis B: From Discovery to Cure
39. Antiviral effect of interferon lambda against West Nile virus
40. Prospects for the Global Elimination of Hepatitis B
41. HBV Drug Resistance Development, Testing, and Prevention
42. Molecular Virology of Hepatitis B Virus for Clinicians
43. Alpha interferon-induced antiviral response noncytolytically reduces replication defective adenovirus DNA in MDBK cells
44. A Putative Amphipathic Alpha Helix in Hepatitis B Virus Small Envelope Protein Plays a Critical Role in the Morphogenesis of Subviral Particles
45. A Southern Blot Assay for Detection of Hepatitis B Virus Covalently Closed Circular DNA from Cell Cultures
46. Viperin vs. tick-borne encephalitis virus: Mechanisms of a potent antiviral protein: 262
47. Chronic hepatitis B: What should be the goal for new therapies?
48. Overview of Hepatitis Viruses and Cancer
49. Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays
50. Hepatitis B virus nucleocapsid uncoating: biological consequences and regulation by cellular nucleases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.